Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 5Sarcoma 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Gliosarcoma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

olaparib 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Cyclophosphamide 4fludarabine 3X-Rays 2Taxes 2Platinum 2Paclitaxel 2Oncolytic Virotherapy 2Letrozole 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorodeoxyglucose F18 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 2Carboplatin 2Aspirin 21,2-diaminocyclohexaneplatinum II citrate 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1pertuzumab 1pembrolizumab 1palbociclib 1niraparib 1montelukast 1gallium 68 PSMA-11 1eribulin 1entrectinib 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ovarian Neoplasms × Irinotecan × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡